#387 - AMA #83: Peptides—evaluating the science, safety, and hype in a rapidly growing field
Listen to the original audio · Transcribed with NVIDIA Parakeet · Timestamps stay in sync with the live audio
Hey everyone, welcome to a sneak peek Ask Me Anything or AMA episode of the Drive podcast. I'm your host, Peter Atiya. At the end of this short episode, I'll explain how you can access the AMA episode episodes in full, along with a ton of other membership benefits we've created. Or you can learn more now by going to peterateiamd.com forward slash subscribe.
So without further delay, here's today's sneak peek of the Ask Me Anything episode. Welcome to Ask Me Anything. In today's AMA, we take on one of the most requested and most confusing topics we've ever covered. Peptides.
Peptides sit at the intersection of biological plausibility, clinical promise, and rampant commercialization. They're often marketed as cutting edge regenerative therapies for everything from muscle repair and longevity to cosmetic enhancements. But the reality is that the peptide ecosystem is sprawling, poorly regulated, and filled with claims that range from legitimate to completely ungrounded. So the goal of this episode is not to promote peptides or dismiss them as a category, but to give you a framework for evaluating them.
We already have this episode, so unlocking it is cheap and permanent: the full transcript (22 minutes, 3,724 words), segment and word-level timestamps, and .txt, .srt, .vtt and word-level JSON downloads, as many times as you like, forever.
No account needed, we create one from your checkout email. With credits it is 1 credit; packs start at 10 episodes for $5, and monthly plans are cheaper still.